COVID-19-related healthcare impacts: an uncontrolled, segmented time-series analysis of tuberculosis diagnosis services in Mozambique, 2017-2020.
COVID-19
Health systems
Tuberculosis
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
31
10
2021
accepted:
27
03
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
23
4
2022
Statut:
ppublish
Résumé
Currently, COVID-19 dominates the public health agenda and poses a permanent threat, leading to health systems' exhaustion and unprecedented service disruption. Primary healthcare services, including tuberculosis services, are at increased risk of facing severe disruptions, particularly in low-income and middle-income countries. Indeed, corroborating model-based forecasts, there is increasing evidence of the COVID-19 pandemic's negative impact on tuberculosis case detection. Applying a segmented time-series analysis, we assessed the effects of COVID-19-related measures on tuberculosis diagnosis service across districts in Mozambique. Ministry health information system data were used from the first quarter of 2017 to the end of 2020. The model, performed under the Bayesian premises, was estimated as a negative binomial with random effects for districts and provinces. A total of 154 districts were followed for 16 consecutive quarters. Together, these districts reported 96 182 cases of all forms of tuberculosis in 2020. At baseline (first quarter of 2017), Mozambique had an estimated incidence rate of 283 (95% CI 200 to 406) tuberculosis cases per 100 000 people and this increased at a 5% annual rate through the end of 2019. We estimated that 17 147 new tuberculosis cases were potentially missed 9 months after COVID-19 onset, resulting in a 15.1% (95% CI 5.9 to 24.0) relative loss in 2020. The greatest impact was observed in the southern region at 40.0% (95% CI 30.1 to 49.0) and among men at 15% (95% CI 4.0 to 25.0). The incidence of pulmonary tuberculosis increased at an average rate of 6.6% annually; however, an abrupt drop (15%) was also observed immediately after COVID-19 onset in March 2020. The most significant impact of the state of emergency was observed between April and June 2020, the quarter after COVID-19 onset. Encouragingly, by the end of 2020, clear signs of health system recovery were visible despite the initial shock.
Identifiants
pubmed: 35443938
pii: bmjgh-2021-007878
doi: 10.1136/bmjgh-2021-007878
pmc: PMC9021460
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
PLoS Med. 2018 Feb 20;15(2):e1002508
pubmed: 29462138
Curr Med Res Pract. 2020 Mar-Apr;10(2):78-79
pubmed: 32292804
Ann Intern Med. 2020 Aug 18;173(4):317-320
pubmed: 32251513
Eur Respir J. 2020 Oct 1;56(4):
pubmed: 32703780
Emerg Infect Dis. 2021 Jul;27(7):1831-1839
pubmed: 34152962
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
EClinicalMedicine. 2020 Oct 24;28:100603
pubmed: 33134905
Lancet Glob Health. 2020 Oct;8(10):e1273-e1281
pubmed: 32791117
WHO South East Asia J Public Health. 2020 Sep;9(2):95-99
pubmed: 32978339
Lancet Glob Health. 2020 Sep;8(9):e1132-e1141
pubmed: 32673577
Indian J Tuberc. 2020 Dec;67(4S):S139-S146
pubmed: 33308660
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32513784
Int J Epidemiol. 2021 Jul 9;50(3):1011-1015
pubmed: 33097937
Int J Environ Res Public Health. 2021 Jan 22;18(3):
pubmed: 33499422
Emerg Infect Dis. 2004 Sep;10(9):1523-8
pubmed: 15498151
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1439-1443
pubmed: 32755848
Lancet Respir Med. 2020 Sep;8(9):844-846
pubmed: 32758439
Lancet Respir Med. 2021 Apr;9(4):340-342
pubmed: 33493446
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33028701
Lancet HIV. 2021 Mar;8(3):e158-e165
pubmed: 33549166
Int J Tuberc Lung Dis. 2020 May 1;24(5):542-544
pubmed: 32398211
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21
pubmed: 32446305
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Lancet Reg Health West Pac. 2020 Oct;3:100032
pubmed: 34173601
Lancet HIV. 2020 May;7(5):e319-e320
pubmed: 32277870
Health Policy Plan. 2016 Feb;31(1):129-35
pubmed: 25887561
Trop Med Infect Dis. 2021 May 19;6(2):
pubmed: 34069332
Lancet HIV. 2020 Sep;7(9):e629-e640
pubmed: 32771089
Am J Respir Crit Care Med. 2012 May 15;185(10):1104-9
pubmed: 22323300
Int J Tuberc Lung Dis. 2021 Jan 1;25(1):81-83
pubmed: 33384053